American Oncology Network, Inc.
AONC
$4.80
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 465.47M | 431.75M | 361.51M | 320.04M | 332.20M |
| Total Other Revenue | 4.81M | 2.23M | 2.83M | 4.14M | 4.11M |
| Total Revenue | 470.28M | 433.98M | 364.34M | 324.18M | 336.31M |
| Cost of Revenue | 433.75M | 404.59M | 354.95M | 312.85M | 310.89M |
| Gross Profit | 36.53M | 29.39M | 9.39M | 11.34M | 25.41M |
| SG&A Expenses | 34.74M | 36.74M | 28.28M | 30.60M | 25.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 468.48M | 441.33M | 383.23M | 343.45M | 336.09M |
| Operating Income | 1.80M | -7.35M | -18.89M | -19.26M | 212.00K |
| Income Before Tax | -1.28M | -3.45M | -22.07M | -22.29M | -13.40M |
| Income Tax Expenses | -- | -324.00K | 2.89M | 69.00K | 315.00K |
| Earnings from Continuing Operations | -1.28M | -3.13M | -24.96M | -22.35M | -13.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 208.00K | 6.75M | 17.12M | 18.60M | 11.92M |
| Net Income | -1.07M | 3.62M | -7.84M | -3.75M | -1.79M |
| EBIT | 1.80M | -7.35M | -18.89M | -19.26M | 212.00K |
| EBITDA | 4.36M | -4.96M | -16.38M | -17.18M | 2.27M |
| EPS Basic | -0.19 | 0.12 | -1.22 | -0.74 | -0.61 |
| Normalized Basic EPS | -0.04 | 0.38 | 0.47 | 0.33 | 1.40 |
| EPS Diluted | -0.19 | -0.11 | -1.22 | -0.74 | -0.61 |
| Normalized Diluted EPS | -0.04 | 0.12 | 0.47 | 0.33 | 1.40 |
| Average Basic Shares Outstanding | 13.26M | 11.38M | 7.53M | 6.90M | 6.61M |
| Average Diluted Shares Outstanding | 13.26M | 37.09M | 7.53M | 6.90M | 6.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -252.80% | -72.94% |
